InvestorsHub Logo
icon url

McMagyar

06/28/19 6:26 PM

#198408 RE: BIOChecker4 #198403

Look ..
We are not in competition, and this post kind of breaks my heart.
Anavex would only compete with another S1r Agonist or be counter productive to a S1r antagonist.

Without even looking I am willing to bet the House Newron is Neither.
So..... we could .....probably be an
ADJUVANT to Newron not a competitor..
And if we are neither but the girls are doing better who cares!
Anavex is. Human Benefit drug that is so powerful it may even effect genetic disorders? That we are even in this space is unbelievable.

People just take a moment and realize what you own..
icon url

Talon38

06/28/19 6:38 PM

#198413 RE: BIOChecker4 #198403

Bio4....Sarizotan has been on RS.org research list for years and its focus on breathing problems is common knowledge. There have been a number of drugs in development for Rett Syndrome. We should be encouraged by success in helping these girls as we believe 2-73 will also do.
icon url

Investor2014

06/29/19 8:49 AM

#198441 RE: BIOChecker4 #198403

Australia?

The first trip… I packed everyone up in Nashville, and stopped half-way in Huntsville, AL where my parents live. My dad, AKA “Papa Coach”, made each and every trip to UAB with us.


A short detour from Nashville Tennessee via Australia to Birmingham Alabama - makes no sense. Nor does the lesson in geography and the seasons.